66 research outputs found

    A Prospective Evaluation of PTSD Symptoms following CPAP Treatment for Sleep-disordered Breathing in Veterans

    Get PDF
    Previous research has observed elevated rates of OSA observed in individuals with PTSD compared to the general population. Retrospective studies suggest that successful treatment of OSA in individuals with PTSD is related to reductions in nightmares and overall PTSD symptom severity. The purpose of the current study was to extend this research by prospectively examining PTSD sympomatology in a sample of Veterans initiating treatment for OSA. Participants were 47 Veterans presenting to a VAMC Neurology Sleep Clinic for overnight polysomnography. Veterans were eligible if they were: (a) diagnosed with OSA; (b) received continuous positive airway pressure (CPAP) treatment; and (c) had a minimum score of 25 on the baseline administration of the PCL. The majority of the sample were male (n = 42; 89.4%) and Caucasian (n = 23; 48.9%) or African American (n = 22; 46.8%), with a mean age of 53.5 years. Veterans completed self-report questionnaires across two pre-treatment and two post-treatment (two weeks and four weeks from treatment initiation) time points. A 2 (treatment compliance status) x 4 (time) mixed model repeated measures analysis was conducted on PTSD symptom severity as measured by the PCL administered at each time point. A statistically significant compliance status x time interaction emerged, (F(3, 102.15) = 5.66. p = .001) such that CPAP-compliant Veterans reported a statistically significant reduction in PTSD symptoms from pre to post-treatment, whereas CPAP non-compliant Veterans did not. These findings suggest that successful treatment of a physical sleep disorder like OSA is associated with a subsequent reduction of posttraumatic distress

    Validation of the Family Inpatient Communication Survey

    Get PDF
    CONTEXT: Although many family members who make surrogate decisions report problems with communication, there is no validated instrument to accurately measure surrogate/clinician communication for older adults in the acute hospital setting. OBJECTIVES: The objective of this study was to validate a survey of surrogate-rated communication quality in the hospital that would be useful to clinicians, researchers, and health systems. METHODS: After expert review and cognitive interviewing (n = 10 surrogates), we enrolled 350 surrogates (250 development sample and 100 validation sample) of hospitalized adults aged 65 years and older from three hospitals in one metropolitan area. The communication survey and a measure of decision quality were administered within hospital days 3 and 10. Mental health and satisfaction measures were administered six to eight weeks later. RESULTS: Factor analysis showed support for both one-factor (Total Communication) and two-factor models (Information and Emotional Support). Item reduction led to a final 30-item scale. For the validation sample, internal reliability (Cronbach's alpha) was 0.96 (total), 0.94 (Information), and 0.90 (Emotional Support). Confirmatory factor analysis fit statistics were adequate (one-factor model, comparative fit index = 0.981, root mean square error of approximation = 0.62, weighted root mean square residual = 1.011; two-factor model comparative fit index = 0.984, root mean square error of approximation = 0.055, weighted root mean square residual = 0.930). Total score and subscales showed significant associations with the Decision Conflict Scale (Pearson correlation -0.43, P < 0.001 for total score). Emotional Support was associated with improved mental health outcomes at six to eight weeks, such as anxiety (-0.19 P < 0.001), and Information was associated with satisfaction with the hospital stay (0.49, P < 0.001). CONCLUSION: The survey shows high reliability and validity in measuring communication experiences for hospital surrogates. The scale has promise for measurement of communication quality and is predictive of important outcomes, such as surrogate satisfaction and well-being

    Evaluation of the National Oceanic and Atmospheric Administration/Coupled-Ocean Atmospheric Response Experiment (NOAA/COARE) air-sea gas transfer parameterization using GasEx data

    Get PDF
    Author Posting. © American Geophysical Union, 2004. This article is posted here by permission of American Geophysical Union for personal use, not for redistribution. The definitive version was published in Journal of Geophysical Research 109 (2004): C08S11, doi:10.1029/2003JC001831.During the two recent GasEx field experiments, direct covariance measurements of air-sea carbon dioxide fluxes were obtained over the open ocean. Concurrently, the National Oceanic and Atmospheric Administration/Coupled-Ocean Atmospheric Response Experiment air-sea gas transfer parameterization was developed to predict gas transfer velocities from measurements of the bulk state of the sea surface and atmosphere. The model output is combined with measurements of the mean air and sea surface carbon dioxide fugacities to provide estimates of the air-sea CO2 flux, and the model is then tuned to the GasEx-1998 data set. Because of differences in the local environment and possibly because of weaknesses in the model, some discrepancies are observed between the predicted fluxes from the GasEx-1998 and GasEx-2001 cases. To provide an estimate of the contribution to the air-sea flux of gas due to wave-breaking processes, the whitecap and bubble parameterizations are removed from the model output. These results show that moderate (approximately 15 m s−1) wind speed breaking wave gas transfer processes account for a fourfold increase in the flux over the modeled interfacial processes.This work was supported by the NOAA Office of Global Programs, under the leadership of Dr. Lisa Dilling. WHOI was supported by the National Science Foundation grant OCE-9711218

    Buildout and integration of an automated high-throughput CLIA laboratory for SARS-CoV-2 testing on a large urban campus

    Get PDF
    In 2019, the first cases of SARS-CoV-2 were detected in Wuhan, China, and by early 2020 the first cases were identified in the United States. SARS-CoV-2 infections increased in the US causing many states to implement stay-at-home orders and additional safety precautions to mitigate potential outbreaks. As policies changed throughout the pandemic and restrictions lifted, there was an increase in demand for COVID-19 testing which was costly, difficult to obtain, or had long turn-around times. Some academic institutions, including Boston University (BU), created an on-campus COVID-19 screening protocol as part of a plan for the safe return of students, faculty, and staff to campus with the option for in-person classes. At BU, we put together an automated high-throughput clinical testing laboratory with the capacity to run 45,000 individual tests weekly by Fall of 2020, with a purpose-built clinical testing laboratory, a multiplexed reverse transcription PCR (RT-qPCR) test, robotic instrumentation, and trained staff. There were many challenges including supply chain issues for personal protective equipment and testing materials in addition to equipment that were in high demand. The BU Clinical Testing Laboratory (CTL) was operational at the start of Fall 2020 and performed over 1 million SARS-CoV-2 PCR tests during the 2020-2021 academic year.Boston UniversityPublished versio

    Lattice QCD and Particle Physics

    Get PDF
    Contribution from the USQCD Collaboration to the Proceedings of the US Community Study on the Future of Particle Physics (Snowmass 2021)

    The genetic architecture of the human cerebral cortex

    Get PDF
    The cerebral cortex underlies our complex cognitive capabilities, yet little is known about the specific genetic loci that influence human cortical structure. To identify genetic variants that affect cortical structure, we conducted a genome-wide association meta-analysis of brain magnetic resonance imaging data from 51,665 individuals. We analyzed the surface area and average thickness of the whole cortex and 34 regions with known functional specializations. We identified 199 significant loci and found significant enrichment for loci influencing total surface area within regulatory elements that are active during prenatal cortical development, supporting the radial unit hypothesis. Loci that affect regional surface area cluster near genes in Wnt signaling pathways, which influence progenitor expansion and areal identity. Variation in cortical structure is genetically correlated with cognitive function, Parkinson's disease, insomnia, depression, neuroticism, and attention deficit hyperactivity disorder

    SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway

    Get PDF
    Vaccines based on the spike protein of SARS-CoV-2 are a cornerstone of the public health response to COVID-19. The emergence of hypermutated, increasingly transmissible variants of concern (VOCs) threaten this strategy. Omicron (B.1.1.529), the fifth VOC to be described, harbours multiple amino acid mutations in spike, half of which lie within the receptor-binding domain. Here we demonstrate substantial evasion of neutralization by Omicron BA.1 and BA.2 variants in vitro using sera from individuals vaccinated with ChAdOx1, BNT162b2 and mRNA-1273. These data were mirrored by a substantial reduction in real-world vaccine effectiveness that was partially restored by booster vaccination. The Omicron variants BA.1 and BA.2 did not induce cell syncytia in vitro and favoured a TMPRSS2-independent endosomal entry pathway, these phenotypes mapping to distinct regions of the spike protein. Impaired cell fusion was determined by the receptor-binding domain, while endosomal entry mapped to the S2 domain. Such marked changes in antigenicity and replicative biology may underlie the rapid global spread and altered pathogenicity of the Omicron variant

    Investigation of hospital discharge cases and SARS-CoV-2 introduction into Lothian care homes

    Get PDF
    Background The first epidemic wave of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in Scotland resulted in high case numbers and mortality in care homes. In Lothian, over one-third of care homes reported an outbreak, while there was limited testing of hospital patients discharged to care homes. Aim To investigate patients discharged from hospitals as a source of SARS-CoV-2 introduction into care homes during the first epidemic wave. Methods A clinical review was performed for all patients discharges from hospitals to care homes from 1st March 2020 to 31st May 2020. Episodes were ruled out based on coronavirus disease 2019 (COVID-19) test history, clinical assessment at discharge, whole-genome sequencing (WGS) data and an infectious period of 14 days. Clinical samples were processed for WGS, and consensus genomes generated were used for analysis using Cluster Investigation and Virus Epidemiological Tool software. Patient timelines were obtained using electronic hospital records. Findings In total, 787 patients discharged from hospitals to care homes were identified. Of these, 776 (99%) were ruled out for subsequent introduction of SARS-CoV-2 into care homes. However, for 10 episodes, the results were inconclusive as there was low genomic diversity in consensus genomes or no sequencing data were available. Only one discharge episode had a genomic, time and location link to positive cases during hospital admission, leading to 10 positive cases in their care home. Conclusion The majority of patients discharged from hospitals were ruled out for introduction of SARS-CoV-2 into care homes, highlighting the importance of screening all new admissions when faced with a novel emerging virus and no available vaccine
    corecore